Patient groups, often wary of diminished access to drugs, silent on Pelosi pricing bill

Advocacy organizations for patients with serious illnesses have been noticeably silent about House Speaker Nancy Pelosi’s bill to lower drug prices ahead of a high-profile House vote this week.

Outside sources close to the debate said many such organizations who fear the measure would curb access to future drugs know they need to be careful about crossing Democrats ahead of a major election, especially when the bill has no chance of becoming law and Congress is closing in on a massive spending deal with numerous healthcare provisions.

The silence is notable given that access to drugs, including the ability to pay for them, is critical for people with severe
Read more…

Please follow and like us:
error